TF and neoplasm: Tumor-bearing mice treated with Tf-NPs loaded with TMZ and the bromodomain inhibitor JQ1 have decreased tumor burden and prolonged survival compared to mice treated with TMZ and JQ1 packaged in non-functionalized NPs or free drug combinations.